![](/img/cover-not-exists.png)
PND15: COST-EFFECTIVENESS OF THERAPY FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS): INTRODUCING AN ECONOMIC MODEL FOR COPAXONE (GLATIRAMER ACETATE)
UK BoseVolume:
4
Year:
2001
Language:
english
DOI:
10.1016/s1098-3015(11)71791-0
File:
PDF, 52 KB
english, 2001